


Grove's AI-accelerated PRM enables clinical research organizations to recruit and engage with participants at scale. At Grove, they’re committed to building purposeful, people-centric, and safe innovations to serve their communities. They’re deeply grateful to their investors, partners, and clinical research leaders—from site coordinators to patient advocates to clinical operations executives—for supporting their mission to advance clinical trials.
Mindpeak's mission is to enable personalised cancer treatment through AI tissue diagnostics. They build automation tools for visual diagnosis using state-of-the-art artificial intelligence and deep learning. They tools assist cancer experts in providing reliable and reproducible diagnoses. This frees specialists from tedious, repetitive tasks such as quantification of cells or biomarkers and allows them to focus on tasks where their human expertise is indispensable.
VideaHealth is on mission to transform dentistry through artificial intelligence. Rooted in AI research conducted at Harvard and MIT, VideaHealth’s FDA-cleared dental AI platform is proven to increase diagnostic accuracy, grow treatment plan values, and improve case acceptance rates.

